These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 642028)

  • 1. Growth inhibition of normal or drug-treated lymphoma cells in lethally irradiated mice.
    Riccardi C; Fioretti MC; Giampietri A; Puccetti P; Goldin A; Bonmassar E
    J Natl Cancer Inst; 1978 May; 60(5):1083-90. PubMed ID: 642028
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell kinetics and immunoegenicity of lymphoma cells treated with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DIC) in vivo.
    Silvestrini R; Testorelli C; Goldin A; Nicolin A
    Int J Cancer; 1977 May; 19(5):664-9. PubMed ID: 863544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro lymphocyte stimulation and the generation of cytotoxic lymphocytes with drug-induced antigenic lymphomas.
    Testorelli C; Franco P; Goldin A; Nicolin A
    Cancer Res; 1978 Mar; 38(3):830-4. PubMed ID: 75062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation resistance of drug-treated allogeneic mice against murine lymphomas--II. Studies with various tumor-host combinations.
    Bonmassar A; Rivosecchi-Merletti P; Barzi A; Goldin A; Bonmassar E
    Int J Immunopharmacol; 1981; 3(4):391-9. PubMed ID: 7333720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Depression of the immune response to lymphoma allotransplant with the use of 5-(3,3-dimethyl-1-triazeno)-imidazol-4-carboxamide (DTIC)].
    Giampietri A; Puccetti P; Circolo A; Menconi E
    Boll Soc Ital Biol Sper; 1977 Jun; 53(11):922-6. PubMed ID: 597414
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired growth of a radiation-induced lymphoma in intact or lethally irradiated allogeneic athymic (nude) mice.
    Bonmassar E; Campanile F; Houchens D; Crino L; Goldin A
    Transplantation; 1975 Oct; 20(4):343-6. PubMed ID: 1162722
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
    Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
    Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth and rejection patterns of murine lymphoma cells antigenically altered following drug treatment in vivo.
    Riccardi C; Fioretti MC; Giampietri A; Puccetti P; Goldin A
    Transplantation; 1978 Feb; 25(2):63-8. PubMed ID: 146282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5056574
    [No Abstract]   [Full Text] [Related]  

  • 10. Transplantation resistance of drug-treated hybrid or allogeneic mice against murine lymphomas. I. Immunopharmacology studies.
    Bonmassar A; Riccardi C; Rivosecchi-Merletti P; Goldin A; Bonmassar E
    Int J Cancer; 1980 Dec; 26(6):819-29. PubMed ID: 6971268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives.
    Puccetti P; Fuschiotti P; Dominici P; Borri-Voltattorni C; Romani L; Fioretti MC
    Int J Cancer; 1987 Jun; 39(6):769-73. PubMed ID: 2438236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes of the immunogenic properties of a radiation-induced mouse lymphoma following treatment with antitumor drugs.
    Bonmassar E; Testorelli C; Franco P; Goldin A; Cudkowicz G
    Cancer Res; 1975 Aug; 35(8):1957-62. PubMed ID: 1149019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated response to a mouse leukemic subline antigenically altered following drug treatment in vivo.
    Nicolin A; Bini A; Franco P; Goldin A
    Cancer Chemother Rep; 1974; 58(3):325-30. PubMed ID: 4841716
    [No Abstract]   [Full Text] [Related]  

  • 15. Attempt to alter antigenic structure of normal tissues by treatment with dimethyl-triazeno-imidazole-carboxamide in vivo.
    Nicolin A; Fagnani R; Nicolotti G; Goldin A
    Experientia; 1976 Jun; 32(6):741-2. PubMed ID: 780128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioresistant inhibition of lymphoma growth in congenitally athymic (nude) mice.
    Campanile F; Crino L; Bonmassar E; Houchens D; Goldin A
    Cancer Res; 1977 Feb; 37(2):394-8. PubMed ID: 832264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfer in vivo of cytotoxic immune lymphocytes obtained in vitro in primary culture against a murine lymphoma antigenically altered by DTIC].
    Romani L; Bianchi R; Nardelli B; Circolo A; Andrielli M
    Boll Soc Ital Biol Sper; 1979 Oct; 55(19):1981-7. PubMed ID: 317993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of immunity in syngeneic lymphoma-bearing mice.
    Jurin M; Plavsić B
    Eur J Cancer (1965); 1978 Jun; 14(6):653-9. PubMed ID: 350589
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiation dose-independent inactivation of isologous mouse lymphoma cells by nonspecific resistance.
    Maruyama Y; Ceman C; McHugh RB
    Cancer Res; 1970 Aug; 30(8):2245-51. PubMed ID: 5459768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.